Jenscare Scientific Co., Ltd. (9877.HK)
- Previous Close
7.240 - Open
7.980 - Bid 7.000 x --
- Ask 7.480 x --
- Day's Range
6.960 - 7.980 - 52 Week Range
1.400 - 7.980 - Volume
1,200,400 - Avg. Volume
271,079 - Market Cap (intraday)
3.02B - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.470 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People's Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; KenFlex, a next-generation transfemoral transcatheter mitral valve (TMVR) repair system product for the treatment of aortic valve regurgitation; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops JensClip, a clip-based transcatheter mitral valve (TMVR) repair system, and JensRelive, a TMVR transfemoral system to treat patients with severe mitral regurgitation; and SimuLock, a bionics left atrial appendage occluder system for cardiogenic stroke prevention. In addition, it is offers cutting-edge JeniGal anti-calcification technology, dry-tissue technology, and polymer leaflet technology, such as robust technical support for the future iteration; and consulting and investment activities. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China.
www.jenscare.comRecent News: 9877.HK
View MorePerformance Overview: 9877.HK
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 9877.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 9877.HK
View MoreValuation Measures
Market Cap
3.12B
Enterprise Value
2.53B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.34
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-11.19%
Return on Equity (ttm)
-17.34%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-177.51M
Diluted EPS (ttm)
-0.470
Balance Sheet and Cash Flow
Total Cash (mrq)
622.81M
Total Debt/Equity (mrq)
7.03%
Levered Free Cash Flow (ttm)
-207.91M